Department of Dermatology and Allergy Biederstein, School of Medicine, Technical University of Munich, Munich, Germany.
Department of Infection and Immunity, Luxembourg Institute of Health (LIH), Esch-sur-Alzette, Luxembourg.
Front Immunol. 2020 Oct 9;11:586924. doi: 10.3389/fimmu.2020.586924. eCollection 2020.
Although first described decades ago, the relevance of carbohydrate specific antibodies as mediators of type I allergy had not been recognized until recently. Previously, allergen specific IgE antibodies binding to carbohydrate epitopes were considered to demonstrate a clinically irrelevant cross-reactivity. However, this changed following the discovery of type I allergies specifically mediated by oligosaccharide structures. Especially the emerging understanding of red meat allergy characterized by IgE directed to the oligosaccharide alpha-gal showed that carbohydrate-mediated reactions can result in life threatening systemic anaphylaxis which in contrast to former assumptions proves a high clinical relevance of some carbohydrate allergens. Within the scope of this review article, we illustrate the historical development of carbohydrate-allergen-research, reaching from only diagnostically relevant crossreactive-carbohydrate-determinants to clinically important antigens mediating type I allergy. Focusing on clinical and immunological features of the alpha-gal syndrome, we highlight the discovery of oligosaccharides as potentially highly immunogenic antigens and mediators of type I allergy, report what is known about the route of sensitization and the immunological mechanisms involved in sensitization and elicitation phase of allergic responses as well as currently available diagnostic and therapeutic tools. Finally, we briefly report on carbohydrates being involved in type I allergies different from alpha-gal.
尽管几十年前就首次描述了这些,但直到最近,碳水化合物特异性抗体作为 I 型过敏的介质的相关性才被认识到。以前,与碳水化合物表位结合的过敏原特异性 IgE 抗体被认为表现出临床无关的交叉反应。然而,随着发现由寡糖结构特异性介导的 I 型过敏,这种情况发生了变化。特别是对由针对寡糖α-半乳糖的 IgE 介导的红肉过敏的新认识表明,碳水化合物介导的反应可导致危及生命的全身性过敏反应,与以前的假设相反,这证明了一些碳水化合物过敏原具有很高的临床相关性。在这篇综述文章的范围内,我们说明了碳水化合物-过敏原研究的历史发展,从仅具有诊断相关性的交叉反应性碳水化合物决定簇到介导 I 型过敏的临床重要抗原。我们重点关注α-半乳糖综合征的临床和免疫学特征,强调了将寡糖作为潜在的高度免疫原性抗原和 I 型过敏介质的发现,报告了关于致敏途径以及参与过敏反应致敏和激发阶段的免疫机制的已知情况,以及目前可用的诊断和治疗工具。最后,我们简要报告了涉及与α-半乳糖不同的 I 型过敏的碳水化合物。